Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1994 1
2001 1
2002 1
2010 2
2012 1
2013 3
2017 1
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Management of in situ and minimally invasive breast carcinoma.
Frykberg ER, Bland KI. Frykberg ER, et al. World J Surg. 1994 Jan-Feb;18(1):45-57. doi: 10.1007/BF00348191. World J Surg. 1994. PMID: 8197776 Review.
In situ breast carcinoma represents an early localized stage in the transition to invasive breast carcinoma and has an especially favorable prognosis with appropriate management. ...Ductal carcinoma in situ behaves more as a true a …
In situ breast carcinoma represents an early localized stage in the transition to invasive breast carcinoma …
In situ breast carcinoma: diagnosis and treatment.
Hindle WH. Hindle WH. Clin Obstet Gynecol. 2002 Sep;45(3):774-7. doi: 10.1097/00003081-200209000-00025. Clin Obstet Gynecol. 2002. PMID: 12370620 Review. No abstract available.
The treatment of in situ breast cancer.
Fentiman IS. Fentiman IS. Acta Oncol. 1989;28(6):923-6. doi: 10.3109/02841868909092333. Acta Oncol. 1989. PMID: 2558695 Review.
However, due to the comparative rarity of in situ breast carcinoma, there is no available information derived from controlled clinical trials. The two major variants, ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (L …
However, due to the comparative rarity of in situ breast carcinoma, there is no available information derived from cont …
Risk of death from breast cancer after treatment for ductal carcinoma in situ.
Wadsten C, Garmo H, Fredriksson I, Sund M, Wärnberg F. Wadsten C, et al. Br J Surg. 2017 Oct;104(11):1506-1513. doi: 10.1002/bjs.10589. Epub 2017 Aug 22. Br J Surg. 2017. PMID: 28832961
BACKGROUND: Studies to date have failed to demonstrate any survival benefit from preventing local recurrence after treatment for ductal breast carcinoma in situ (DCIS). Patient- and tumour-related risk factors for death from breast cancer in women with …
BACKGROUND: Studies to date have failed to demonstrate any survival benefit from preventing local recurrence after treatment for ductal b …
Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S, Ter Braak BPM, Plaisier PW, van Rosmalen J, Menke-Pluijmers MBE, Westenend PJ. van Bekkum S, et al. Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1854-1860. doi: 10.1016/j.ejso.2020.05.028. Epub 2020 Jun 24. Eur J Surg Oncol. 2020. PMID: 32624292
Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal carcinoma in situ (DCIS) and a high risk of occult invasive cancer. ...RESULTS: Of 211 patients eligible for additional MRI analysis, 149 underwent breast MRI. The majority (67 …
Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal carcinoma in situ (DCIS) and a high risk of …
Can we improve breast cancer management using an image-guided histopathology workup supported by larger histopathology sections?
Tabár L, Dean PB, Lee Tucker F, Vörös A. Tabár L, et al. Eur J Radiol. 2023 Apr;161:110750. doi: 10.1016/j.ejrad.2023.110750. Epub 2023 Feb 18. Eur J Radiol. 2023. PMID: 36821956 Review.
PURPOSE: Breast radiologists examine the entire breast in full-size images, while breast pathologists examine small tissue samples at high magnification. ...Uncertainty of surgical margin evaluation inherent to the standard small section technique can lead to …
PURPOSE: Breast radiologists examine the entire breast in full-size images, while breast pathologists examine small tis …
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
Cutuli B, Lemanski C, Le Blanc-Onfroy M, de Lafontan B, Cohen-Solal-Le-Nir C, Fondrinier E, Mignotte H, Giard S, Charra-Brunaud C, Auvray H, Gonzague-Casabianca L, Quétin P, Fay R. Cutuli B, et al. Cancer Radiother. 2013 Jun;17(3):196-201. doi: 10.1016/j.canrad.2013.01.011. Epub 2013 Mar 26. Cancer Radiother. 2013. PMID: 23538041
PURPOSE: Ductal carcinoma in situ overall prognosis is excellent, but after breast conserving surgery, with or without radiotherapy, local recurrences can lead to locoregional or distant evolution and death. ...Among invasive local recurrences, comedocarcinom …
PURPOSE: Ductal carcinoma in situ overall prognosis is excellent, but after breast conserving surgery, with or without …
Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ.
Mangla B, Mittal P, Kumar P, Javed S, Ahsan W, Aggarwal G. Mangla B, et al. Nanomedicine (Lond). 2024 Apr;19(10):855-874. doi: 10.2217/nnm-2023-0260. Epub 2024 Mar 5. Nanomedicine (Lond). 2024. PMID: 38440976
Conclusion: Optimized ERL@TG was identified as a promising avenue for addressing ductal carcinoma in situ breast cancer. Despite progress, breast cancer remains a significant cause of death. This study aimed to revolutionize the treatment of noninvasiv …
Conclusion: Optimized ERL@TG was identified as a promising avenue for addressing ductal carcinoma in situ breast cancer …
Breast conserving surgery in the management of in situ breast carcinoma.
Graham MD, Lakhani S, Gazet JC. Graham MD, et al. Eur J Surg Oncol. 1991 Jun;17(3):258-64. Eur J Surg Oncol. 1991. PMID: 1646128
In a retrospective review of 73 patients with in situ breast carcinoma seen in the Combined Breast Clinic at the Royal Marsden and St. George's Hospitals between 1969 and 1988, 20 (27%) were found to have in situ lobular and 53 (73%) in situ …
In a retrospective review of 73 patients with in situ breast carcinoma seen in the Combined Breast Clinic at the …
Multidisciplinary management of mammary Paget's disease: recommendations to optimize oncological and aesthetic outcomes.
Franceschini G, Mason EJ, Di Leone A, Scardina L, Masetti R. Franceschini G, et al. Ann Ital Chir. 2022;93:481-482. Ann Ital Chir. 2022. PMID: 36196555
Mammary Paget's Disease (MPD) or Paget's disease of the breast is an uncommon pathology which accounts for less than 5% of breast cancers 1-3. ...Instead, skin-sparing mastectomy with immediate breast reconstruction is indicated for MPD associated to multicen …
Mammary Paget's Disease (MPD) or Paget's disease of the breast is an uncommon pathology which accounts for less than 5% of breast …
15 results